211 related articles for article (PubMed ID: 19577278)
1. Plasma calprotectin concentrations in women with endometrial carcinoma.
Ni Bhriain H; Trovik J; Wik E; Stefansson IM; Akslen LA; Salvesen HB; Staff AC
Gynecol Oncol; 2009 Sep; 114(3):491-5. PubMed ID: 19577278
[TBL] [Abstract][Full Text] [Related]
2. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary.
Ødegaard E; Davidson B; Elgaaen BV; Fagerhol MK; Engh V; Onsrud M; Staff AC
Am J Obstet Gynecol; 2008 Apr; 198(4):418.e1-7. PubMed ID: 18241816
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
6. Shed membrane fragment-associated markers for endometrial and ovarian cancers.
Taylor DD; Lyons KS; Gerçel-Taylor C
Gynecol Oncol; 2002 Mar; 84(3):443-8. PubMed ID: 11855885
[TBL] [Abstract][Full Text] [Related]
7. Calprotectin plasma level is elevated in preeclampsia.
Holthe MR; Staff AC; Berge LN; Fagerhol MK; Lyberg T
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):151-4. PubMed ID: 15683375
[TBL] [Abstract][Full Text] [Related]
8. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
Joshi S; Lewis SJ; Creanor S; Ayling RM
Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
[TBL] [Abstract][Full Text] [Related]
9. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
Zhang AM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer.
Staff AC; Bock AJ; Becker C; Kempf T; Wollert KC; Davidson B
Gynecol Oncol; 2010 Sep; 118(3):237-43. PubMed ID: 20576287
[TBL] [Abstract][Full Text] [Related]
12. Midkine and its clinical significance in endometrial carcinoma.
Tanabe K; Matsumoto M; Ikematsu S; Nagase S; Hatakeyama A; Takano T; Niikura H; Ito K; Kadomatsu K; Hayashi S; Yaegashi N
Cancer Sci; 2008 Jun; 99(6):1125-30. PubMed ID: 18422745
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
14. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
[TBL] [Abstract][Full Text] [Related]
15. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
16. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia.
Braekke K; Holthe MR; Harsem NK; Fagerhol MK; Staff AC
Am J Obstet Gynecol; 2005 Jul; 193(1):227-33. PubMed ID: 16021084
[TBL] [Abstract][Full Text] [Related]
17. High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
Honkavuori M; Talvensaari-Mattila A; Puistola U; Turpeenniemi-Hujanen T; Santala M
Anticancer Res; 2008; 28(5A):2715-9. PubMed ID: 19035300
[TBL] [Abstract][Full Text] [Related]
18. Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?
Navarria I; Usel M; Rapiti E; Neyroud-Caspar I; Pelte MF; Bouchardy C; Petignat P
Gynecol Oncol; 2009 Sep; 114(3):448-51. PubMed ID: 19560801
[TBL] [Abstract][Full Text] [Related]
19. [Plasma calprotectin. A new prognostic marker of survival in alcoholic liver cirrhosis].
Homann C; Garred P; Graudal NA; Hasselqvist P; Christiansen M; Fagerhol MK; Thomsen AC
Ugeskr Laeger; 1996 May; 158(21):2980-4. PubMed ID: 8686035
[TBL] [Abstract][Full Text] [Related]
20. Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis.
Homann C; Garred P; Graudal N; Hasselqvist P; Christiansen M; Fagerhol MK; Thomsen AC
Hepatology; 1995 Apr; 21(4):979-85. PubMed ID: 7705809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
